The reaction between carbon dioxide and epoxides is an attractive pathway for CO2-utilisation as it can lead to the formation of two valuable products: cyclic and polymeric carbonates.
A novel catalyst design for the conversion of mono- and disaccharides to lactic acid and its alkyl esters was developed. The design uses a mesoporous silica, here represented by MCM-41, which is filled with a polyaromatic to graphite-like carbon network. The particular structure of the carbon-silica composite allows the accommodation of a broad variety of catalytically active functions, useful to attain cascade reactions, in a readily tunable pore texture. The significance of a joint action of Lewis and weak Brønsted acid sites was studied here to realize fast and selective sugar conversion. Lewis acidity is provided by grafting the silica component with Sn(IV), while weak Brønsted acidity originates from oxygen-containing functional groups in the carbon part. The weak Brønsted acid content was varied by changing the amount of carbon loading, the pyrolysis temperature, and the post-treatment procedure. As both catalytic functions can be tuned independently, their individual role and optimal balance can be searched for. It was thus demonstrated for the first time that the presence of weak Brønsted acid sites is crucial in accelerating the rate-determining (dehydration) reaction, that is, the first step in the reaction network from triose to lactate. Composite catalysts with well-balanced Lewis/Brønsted acidity are able to convert the trioses, glyceraldehyde and dihydroxyacetone, quantitatively into ethyl lactate in ethanol with an order of magnitude higher reaction rate when compared to the Sn grafted MCM-41 reference catalyst. Interestingly, the ability to tailor the pore architecture further allows the synthesis of a variety of amphiphilic alkyl lactates from trioses and long chain alcohols in moderate to high yields. Finally, direct lactate formation from hexoses, glucose and fructose, and disaccharides composed thereof, sucrose, was also attempted. For instance, conversion of sucrose with the bifunctional composite catalyst yields 45% methyl lactate in methanol at slightly elevated reaction temperature. The hybrid catalyst proved to be recyclable in various successive runs when used in alcohol solvent.
The acetalization of acetone with glycerol to yield 2,2-dimethyl-1,3-dioxolane-4-methanol (solketal) was successfully catalyzed by mesoporous substituted silicates including the novel Hf-TUD-1 material. This reaction offers an attractive path for the conversion of glycerol, which is the main side-product in the synthesis of biodiesel, to a valuable compound with potential for industrial applications. The most promising among the heterogeneous catalysts employed in this work, Zr-and Hf-TUD-1 and Sn-MCM-41, display mainly Lewis acid properties as demonstrated by characterization with FT-IR analysis of pyridine adsorption, and achieve superior results compared to a reference solid acid catalyst such as Ultrastable zeolite Y. Especially the newly synthesized Hf-TUD-1, showing the highest conversion and turnover among the screened materials, is a promising catalyst for the acetalization of acetone with glycerol in a sustainable process. The excellent performance of these mesoporous catalysts is ascribed to their combination of acidity, wide pores, large specific surface area and relatively hydrophobic surface.Scheme 1 Solketal prepared from the acetalization of acetone with glycerol. † Electronic supplementary information (ESI) available: Comparison between heterogeneous catalysts for the conversion of glycerol to solketal. See
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.